MATINAS BIOPHARMA HOLDINGS INC (MTNB)
AMEXHealth CareBiotechnologySnapshot 2026-11-04
$1.16-2.52%
Close 2026-11-05 · 1-day change
AMEXHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · MTNB
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance sits below its industry cohort — worth keeping an eye on, though it has not freshly broken.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | -64.9% |
| Our one-year growth estimate | diamond | Not available |
Growth built into the price is above our model estimate.
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A comparable growth gap is not available.
The one-year revenue growth assumption on Valuation.
Worth watching into the next print: this name is a smaller-cap name (higher miss base rate) and operates in a high-miss-rate industry. A fundamental tilt, not a price call.
Model as of 2026-11-04 · Compared with 66 industry peers
MTNB — capital allocation — Material
Dated 2026-09-28
Material Modification to the Rights of Security Holders. The information contained in
Why it matters: Approval is crucial for Matinas to maintain its listing on the NYSE American. Failure to comply could lead to delisting.
Worry ifThe NYSE American agrees with Matinas' plan. They must meet the deadline by October 2, 2027.
Less concerning ifThe NYSE American rejects the plan or Matinas fails to show progress by the deadline.
Why it matters: Better operating income shows the company is making progress. It means fewer losses.
Supportive ifQ2 2026 operating income shows improvement from -$1.936M in Q1 2026.
Worry ifQ2 2026 operating income worsens or remains at -$1.936M or worse.
Why it matters: Increasing stockholders' equity is important. It helps Matinas stay compliant with NYSE rules.
Supportive ifMatinas will show over $2 million in stockholders' equity in its next report.
Worry ifStockholders' equity will be below $2 million in the next report.
Why it matters: Matinas needs more money to keep running during losses. This affects financial stability.
Worry ifMatinas announces a new financing round raising at least $1 million.
Less concerning ifNo new financing is announced, leading to potential cash flow issues.
A larger daily loss that occurred about once in every 20 trading days.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$429 on $10,000 · ±4.3% | How much price usually moves either way. |
| Bad day | $1,227 loss on $10,000 · 12.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $9,406 loss on $10,000 · 94.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.
Why it matters: The company faces a risk of delisting due to non-compliance. Progress here is crucial for stability.
Worry ifManagement announces a plan to meet NYSE compliance standards by the next quarter.
Less concerning ifNo progress has been reported. This leads to more notices from NYSE American.
Why it matters: This merger could help Matinas in clean energy and critical minerals. It may affect stockholder value.
Supportive ifThe business combination will close as planned in Q4 2026. This will help growth.
Worry ifThe business combination is delayed or does not close. This will hurt growth plans.
Why it matters: Azurity would take over MAT2203 and the LNC platform. Matinas would receive $4 million upfront, plus possible later payments and royalties.
Supportive ifMatinas stockholders approve the sale. The $4 million upfront payment is made at closing.
Worry ifStockholders reject the sale, or the sale does not close with the GH Power merger.
Why it matters: Matinas has raised cash through preferred shares and warrants. More share issuance could reduce current holders' ownership.
Worry ifA filing reports another equity or warrant deal. The deal adds shares beyond the July 2026 Series D financing and its 1,642,856 warrants.
Less concerning ifA filing confirms there is no new share-linked financing. The Series D shares and warrants add no further shares.
Why it matters: Starting the Phase 3 trial is crucial for MAT2203's market potential and revenue generation.
Supportive ifMatinas announces the initiation of the Phase 3 trial for MAT2203.
Worry ifNo announcement of trial initiation by the end of 2026.
Why it matters: The company must regain compliance with NYSE standards to avoid delisting. This affects investor confidence and stock value.
Worry ifMatinas meets NYSE standards. Stockholders' equity is above $2 million.
Less concerning ifMatinas does not meet compliance standards. This may lead to delisting.
Why it matters: The sale could unlock value for Matinas and provide needed capital. It is a key step in their strategic shift.
Supportive ifThe sale of MAT2203 is done. It provides $4 million upfront and possible milestone payments.
Worry ifThe sale is delayed or does not happen. This will hurt Matinas's financial outlook.
Why it matters: This is a stated condition of the merger. The money would support GH Power's project plans.
Watch forGH Power completes a financing that brings in at least $15 million before the merger closes.
Also watch forGH Power fails to raise $15 million, and the merger does not waive this condition.
Why it matters: The merger would turn Matinas into a clean energy company. A delay or failed close would leave that change in doubt.
Watch forThe merger closes by December 31, 2026. Required votes, court and SEC steps, $15 million in financing, and NYSE American listing approval are complete.
Also watch forThe merger misses the December 31, 2026 deadline. Or a required vote, approval, financing, or listing step fails.
Why it matters: Smaller losses would support the reported trend toward better financial stability. A larger loss would weaken that signal.
Watch forThe November 9 report shows an operating loss below $1.56 million. That was the amount reported for 2026-Q2.
Also watch forThe November 9 report shows an operating loss of $1.56 million or more.